Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.

The Expert View: Glaxosmithkline, Burford Capital And Gvc

by posted 9months ago 55 views
Our daily roundup of analyst commentary on shares, also including Mitie and Miton. : Click on the arrow to the right of the picture to view the slides. The arrows to the top right then allow you to move back and forth between them. GlaxoSmithKline (GSK) has announced a surprise consumer healthcare joint venture with Pfizer that should take a strain off the balance sheet, says Hargreaves Lansdown. The joint venture will have £9.8 billion in annual sales, with Glaxo taking a 68% stake and the aim being to list the company in three years.

In this article